DAKOTACARE update: how PhRMA is changing their approach to key generic launches, observations in the marketplace.
作者信息
Weiss Danny
出版信息
S D Med. 2013 Jun;66(6):245-6.
PMID:23923686
Abstract
摘要
相似文献
1
DAKOTACARE update: how PhRMA is changing their approach to key generic launches, observations in the marketplace.
S D Med. 2013 Jun;66(6):245-6.
2
Drugs: budget busters or cost cutters in future health care?药物：未来医疗保健中的预算杀手还是成本削减者？
Health Care Strateg Manage. 1999 Mar;17(3):1, 22-3.
3
Who's really raising drug prices?究竟是谁在真正抬高药价？
Time. 1999 Mar 8;153(9):46-8.
4
Rx for investors.投资者的处方。
Fortune. 2004 May 3;149(9):158-60, 162, 164 passim.
5
Generic drugs: the stalling game.仿制药：停滞不前的局面。
Consum Rep. 2001 Jul;66(7):36-40.
6
What makes a good forecaster?
Nat Rev Drug Discov. 2003 Jan;2(1):83. doi: 10.1038/nrd1005.
7
Prescription drugs and health care reform.处方药与医疗保健改革。
Pharmacotherapy. 1993 Nov-Dec;13(6):583-9.
8
Upcoming market catalysts in Q4 2009.
Nat Rev Drug Discov. 2009 Oct;8(10):763. doi: 10.1038/nrd3004.
9
Vertical integration: the drug industry and prescription benefits managers.
Pharmacotherapy. 1995 May-Jun;15(3):265-71.
10
Handle with care.
Nature. 2006 Apr 20;440(7087):990-1. doi: 10.1038/440990a.
Zotero 插件